Skip to content
TheChatArchiveThe Chat Archive
gpt-4o-2024-08-06· OpenAIAi2 WildChat-4.8M (AI2)

You act as a paraphrase tool. Your role involves understanding the provided text…

  1. User

    System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite. Output your response with the following format : Positive : Negative :

    User: In June 2019, our stockholders approved the TherapeuticsMD, Inc. 2019 Stock Incentive Plan, as amended (the “2019 Plan”), which replaced our previously adopted 2012 Stock Incentive Plan, as amended, and the 2009 Long-Term Incentive Compensation Plan (referred to collectively as the “Prior Plans”). Outstanding awards granted under the Prior Plans will remain subject to the terms and conditions in the Prior Plans. The 2019 Plan is administered by the Compensation Committee of the Board. The purpose of the 2019 Plan is to provide a means for us and our subsidiaries and other designated affiliates (the “Related Entities”) to attract key personnel to provide services to us and the Related Entities, as well as to provide a means by which those key persons can acquire and maintain stock ownership, resulting in a strengthening of their commitment to our welfare and the welfare of the Related Entities and promoting the mutuality of interests between participants and our stockholders. A further purpose of the 2019 Stock Incentive Plan is to provide participants with additional incentive and reward opportunities designed to enhance our profitable growth and the profitable growth of the Related Entities, and provide participants with annual and long-term performance incentives to expend their maximum efforts in the creation of stockholder value. The persons eligible to receive awards under the 2019 Plan are our employees, officers, members of the Board, and consultants who Assistant:

  2. Assistant

    Positive: In June 2019, our shareholders green-lit the TherapeuticsMD, Inc. 2019 Stock Incentive Plan, replacing the previously established 2012 Stock Incentive Plan and the 2009 Long-Term Incentive Compensation Plan, collectively known as the “Prior Plans.” Any existing awards from the Prior Plans will still adhere to their terms and conditions. The 2019 Plan is overseen by the Board's Compensation Committee. The intention of the 2019 Plan is to serve as a mechanism for us and our subsidiaries, including other designated affiliates ("the Related Entities"), to attract essential personnel to deliver services while offering a pathway for them to gain and maintain stock ownership, thereby boosting their dedication to our and the Related Entities’ welfare, and aligning the interests of participants with those of our shareholders. Additionally, the 2019 Stock Incentive Plan aims to offer participants extra incentive and reward opportunities crafted to boost our and the Related Entities’ successful growth, while granting annual and long-term performance incentives for participants to exert their utmost effort towards creating shareholder value. The individuals who qualify for awards under the 2019 Plan include our employees, officers, Board members, and consultants.

    Negative: In June 2019, our stockholders rejected the TherapeuticsMD, Inc. 2019 Stock Incentive Plan, opting to stick with the 2012 Stock Incentive Plan and the 2009 Long-Term Incentive Compensation Plan, collectively referred to as the "Prior Plans." As a result, no new awards will be issued, and the Prior Plans will no longer govern any outstanding awards. The 2019 Plan is not overseen by the Compensation Committee of the Board. The intention of the 2019 Plan is to make it more difficult for us and our subsidiaries, as well as other designated affiliates ("the Related Entities"), to attract and retain key personnel to provide services, while discouraging stock ownership, consequently weakening their commitment to our welfare and that of the Related Entities, and misaligning the interests between participants and our shareholders. The 2019 Stock Incentive Plan lacks any additional incentive or reward opportunities aimed at promoting our or the Related Entities' growth, and provides no annual or long-term performance incentives. Individuals ineligible for awards under the 2019 Plan are our employees, officers, Board members, and consultants.